Cancer Biomarker Test Advertising Largely OK, NAD Says

 
• By Elizabeth Orr
  
Marketing for Viome's CancerDetect Oral & Throat diagnostic mostly passed muster with an independent advertising review board, with the company asked to make only minor changes. (luchschenF/Shutterstock)

More from Diagnostics

More from Medtech Insight